Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.

MLA

van Dussen, Laura, et al. “Effects of Switching from a Reduced Dose Imiglucerase to Velaglucerase in Type 1 Gaucher Disease: Clinical and Biochemical Outcomes.” Haematologica, vol. 97, no. 12, Dec. 2012, pp. 1850–54. EBSCOhost, https://doi.org/10.3324/haematol.2011.059071.

APA

van Dussen, L., Cox, T. M., Hendriks, E. J., Morris, E., Akkerman, E. M., Maas, M., Groener, J. E. M., Aerts, J. M. F. G., Deegan, P. B., & Hollak, C. E. M. (2012). Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes. Haematologica, 97(12), 1850–1854. https://doi.org/10.3324/haematol.2011.059071

Chicago

van Dussen, Laura, Timothy M Cox, Erik J Hendriks, Elizabeth Morris, Erik M Akkerman, Mario Maas, Johanna E M Groener, Johannes M F G Aerts, Patrick B Deegan, and Carla E M Hollak. 2012. “Effects of Switching from a Reduced Dose Imiglucerase to Velaglucerase in Type 1 Gaucher Disease: Clinical and Biochemical Outcomes.” Haematologica 97 (12): 1850–54. doi:10.3324/haematol.2011.059071.